DISCOUNT-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 05:45:22 2024-06-28 EDT | ||
| 0.66 EUR | 0.00% |
|
| Current month | -8.33% | ||
| 1 month | -1.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 0.66 | 0.00% |
| 24-06-27 | 0.66 | +4.76% |
| 24-06-26 | 0.63 | +8.62% |
| 24-06-25 | 0.58 | -4.92% |
| 24-06-24 | 0.61 | -10.29% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 05:45 am
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD4KBK |
| ISIN | DE000HD4KBK5 |
| Date issued | 2024-04-11 |
| Strike | 285 $ |
| Maturity | 2024-12-18 (174 Days) |
| Parity | 10 : 1 |
| Emission price | 1.29 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.3 € |
|---|---|
| Lowest since issue | 0.56 € |
| Spread | 0.06 € |
| Spread % | 9.09% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
313.7
USD
Average target price
316.4
USD
Spread / Average Target
+0.88%
- Stock Market
- Certificates
- Certificat
